VAHAB FATOURECHI, M.D.; HUNTER HEATH, M.D.
Postmenopausal osteoporosis is a common disorder and a major public health problem (1). It is hoped that appropriate intervention will reduce morbidity and mortality resulting from vertebral and hip fractures complicating the disease. The National Institutes of Health Consensus Conference on Osteoporosis (2) has recommended a calcium intake of 1000 to 1500 mg per day for all postmenopausal women and has advised that postmenopausal estrogen replacement therapy should be considered individually by the patient and her physician. This preventive approach is supported by extensive basic, clinical, and epidemiologic research (3), and the therapeutic benefit of estrogen in established postmenopausal osteoporosis
Learn more about subscription options.
Register Now for a free account.
FATOURECHI V, HEATH H. Salmon Calcitonin in the Treatment of Postmenopausal Osteoporosis. Ann Intern Med. 1987;107:923-925. doi: 10.7326/0003-4819-107-6-923
Download citation file:
Published: Ann Intern Med. 1987;107(6):923-925.
Endocrine and Metabolism, Metabolic Bone Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only